GoodRx director granted 73,434 RSUs in stock award
REY-GIRAUD AGNES reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
REY-GIRAUD AGNES reported acquisition or exercise transactions in this Form 4 filing.
GoodRx Holdings, Inc. director Agnes Rey-Giraud reported an equity compensation grant in the form of restricted stock units covering 73,434 shares of Class A common stock. These units were awarded at no cash cost to her and represent a contingent right to receive shares in the future.
The restricted stock units vest in full on the earlier of the one-year anniversary of June 16, 2026 or the date of the company’s 2027 Annual Meeting of Stockholders, assuming she continues her service through that date. Following this grant, she holds 426,286 shares of Class A common stock directly, reflecting a routine director compensation award rather than an open-market purchase.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A Common Stock | 73,434 | $0.00 | $0.00 |
Footnotes (1)
- F1. Reflects restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The restricted stock units vest in full on the earlier of (i) the one-year anniversary of June 16, 2026 and (ii) the date of the 2027 Annual Meeting of Stockholders, subject to Reporting Person's continued service through the applicable vesting date.
Key Figures
Key Terms
restricted stock units financial
contingent right financial
Annual Meeting of Stockholders financial
continued service financial
AI-generated analysis. How Rhea-AI works. Not financial advice.